{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:37:43Z","timestamp":1793299063213,"version":"4.5.0"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,9,11]],"date-time":"2012-09-11T00:00:00Z","timestamp":1347321600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1038\/nrendo.2012.155","type":"journal-article","created":{"date-parts":[[2012,9,11]],"date-time":"2012-09-11T10:20:15Z","timestamp":1347358815000},"page":"668-678","source":"Crossref","is-referenced-by-count":53,"title":["Adrenal disorders in pregnancy"],"prefix":"10.1038","volume":"8","author":[{"given":"Silvia","family":"Monticone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Auchus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Rainey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,11]]},"reference":[{"key":"BFnrendo2012155_CR1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1055\/s-2004-861549","volume":"22","author":"WE Rainey","year":"2004","unstructured":"Rainey, W. E., Rehman, K. S. & Carr, B. R. The human fetal adrenal: making adrenal androgens for placental estrogens. Semin. Reprod. Med. 22, 327\u2013336 (2004).","journal-title":"Semin. Reprod. Med."},{"key":"BFnrendo2012155_CR2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1210\/er.2010-0001","volume":"32","author":"H Ishimoto","year":"2011","unstructured":"Ishimoto, H. & Jaffe, R. B. Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit. Endocr. Rev. 32, 317\u2013355 (2011).","journal-title":"Endocr. Rev."},{"key":"BFnrendo2012155_CR3","first-page":"791","volume":"23","author":"E Diczfalusy","year":"1964","unstructured":"Diczfalusy, E. Endocrine functions of the human fetoplacental unit. Fed. Proc. 23, 791\u2013798 (1964).","journal-title":"Fed. Proc."},{"key":"BFnrendo2012155_CR4","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1210\/er.2004-0025","volume":"26","author":"JR Lindsay","year":"2005","unstructured":"Lindsay, J. R. & Nieman, L. K. The hypothalamic\u2013pituitary\u2013adrenal axis in pregnancy: challenges in disease detection and treatment. Endocr. Rev. 26, 775\u2013799 (2005).","journal-title":"Endocr. Rev."},{"key":"BFnrendo2012155_CR5","first-page":"1184","volume":"77","author":"S Mesiano","year":"1993","unstructured":"Mesiano, S., Coulter, C. L. & Jaffe, R. B. Localization of cytochrome P450 cholesterol side-chain cleavage, cytochrome P450 17\u03b1-hydroxylase\/17, 20-lyase, and 3 \u03b2-hydroxysteroid dehydrogenase isomerase steroidogenic enzymes in human and rhesus monkey fetal adrenal glands: reappraisal of functional zonation. J. Clin. Endocrinol. Metab. 77, 1184\u20131189 (1993).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1210\/jc.2005-2720","volume":"92","author":"S Ben-David","year":"2007","unstructured":"Ben-David, S. et al. Parturition itself is the basis for fetal adrenal involution. J. Clin. Endocrinol. Metab. 92, 93\u201397 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR7","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1172\/JCI25091","volume":"116","author":"M Goto","year":"2006","unstructured":"Goto, M. et al. In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development. J. Clin. Invest. 116, 953\u2013960 (2006).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo2012155_CR8","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S1071-55760300118-7","volume":"10","author":"KS Rehman","year":"2003","unstructured":"Rehman, K. S., Carr, B. R. & Rainey, W. E. Profiling the steroidogenic pathway in human fetal and adult adrenals. J. Soc. Gynecol. Investig. 10, 372\u2013380 (2003).","journal-title":"J. Soc. Gynecol. Investig."},{"key":"BFnrendo2012155_CR9","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1210\/jcem-26-7-751","volume":"26","author":"PK Siiteri","year":"1966","unstructured":"Siiteri, P. K. & MacDonald, P. C. Placental estrogen biosynthesis during human pregnancy. J. Clin. Endocrinol. Metab. 26, 751\u2013761 (1966).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1530\/acta.0.0450535","volume":"45","author":"E Bolte","year":"1964","unstructured":"Bolte, E., Mancuso, S., Eriksson, G., Wiqvist, N. & Diczfalusy, E. Studies on the aromatisation of neutral steroids in pregnant women. I. Aromatisation of C-19 steroids by placentas perfused in situ. Acta Endocrinol. (Copenh.) 45, 535\u2013559 (1964).","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"BFnrendo2012155_CR11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1210\/jcem-51-2-223","volume":"51","author":"S Pang","year":"1980","unstructured":"Pang, S. et al. Amniotic fluid concentrations of \u03945 and \u03944 steroids in fetuses with congenital adrenal hyperplasia due to 21 hydroxylase deficiency and in anencephalic fetuses. J. Clin. Endocrinol. Metab. 51, 223\u2013229 (1980).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1210\/jcem-48-1-133","volume":"48","author":"JE Buster","year":"1979","unstructured":"Buster, J. E. et al. Interrelationships of circulating maternal steroid concentrations in third trimester pregnancies. I. C21 steroids: progesterone, 16\u03b1-hydroxyprogesterone, 17\u03b1-hydroxyprogesterone, 20\u03b1-dihydroprogesterone, \u03945-pregnenolone sulfate and 17-hydroxy \u03945-pregnenolone. J. Clin. Endocrinol. Metab. 48, 133\u2013138 (1979).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR13","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMoa070641","volume":"357","author":"DJ Rouse","year":"2007","unstructured":"Rouse, D. J. et al. A trial of 17 \u03b1-hydroxyprogesterone caproate to prevent prematurity in twins. N. Engl. J. Med. 357, 454\u2013461 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo2012155_CR14","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","volume":"348","author":"PJ Meis","year":"2003","unstructured":"Meis, P. J. et al. Prevention of recurrent preterm delivery by 17 \u03b1-hydroxyprogesterone caproate. N. Engl. J. Med. 348, 2379\u20132385 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo2012155_CR15","first-page":"214","volume":"55","author":"J Bocian-Sobkowska","year":"1996","unstructured":"Bocian-Sobkowska, J., Malendowicz, L. K., Wozniak, W. & Kopaczyk, M. Adrenal glands in anencephaly. Folia Morphol. (Warsz.) 55, 214\u2013216 (1996).","journal-title":"Folia Morphol. (Warsz.)"},{"key":"BFnrendo2012155_CR16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0303-7207(99)00118-5","volume":"155","author":"CR Parker Jr","year":"1999","unstructured":"Parker, C. R. Jr, Stankovic, A. M. & Goland, R. S. Corticotropin-releasing hormone stimulates steroidogenesis in cultured human adrenal cells. Mol. Cell Endocrinol. 155, 19\u201325 (1999).","journal-title":"Mol. Cell Endocrinol."},{"key":"BFnrendo2012155_CR17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1210\/jc.2004-0865","volume":"90","author":"R Sirianni","year":"2005","unstructured":"Sirianni, R., Rehman, K. S., Carr, B. R., Parker, C. R. Jr & Rainey, W. E. Corticotropin-releasing hormone directly stimulates cortisol and the cortisol biosynthetic pathway in human fetal adrenal cells. J. Clin. Endocrinol. Metab. 90, 279\u2013285 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR18","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1210\/jc.2005-0680","volume":"90","author":"R Sirianni","year":"2005","unstructured":"Sirianni, R., Mayhew, B. A., Carr, B. R., Parker, C. R. Jr & Rainey, W. E. Corticotropin-releasing hormone (CRH) and urocortin act through type 1 CRH receptors to stimulate dehydroepiandrosterone sulfate production in human fetal adrenal cells. J. Clin. Endocrinol. Metab. 90, 5393\u20135400 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR19","first-page":"2916","volume":"83","author":"R Smith","year":"1998","unstructured":"Smith, R., Mesiano, S., Chan, E. C., Brown, S. & Jaffe, R. B. Corticotropin-releasing hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion by human fetal adrenal cortical cells. J. Clin. Endocrinol. Metab. 83, 2916\u20132920 (1998).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR20","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/328717a0","volume":"328","author":"F Petraglia","year":"1987","unstructured":"Petraglia, F., Sawchenko, P. E., Rivier, J. & Vale, W. Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta. Nature 328, 717\u2013719 (1987).","journal-title":"Nature"},{"key":"BFnrendo2012155_CR21","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1210\/jcem-63-5-1199","volume":"63","author":"RS Goland","year":"1986","unstructured":"Goland, R. S., Wardlaw, S. L., Stark, R. I., Brown, L. S. Jr & Frantz, A. G. High levels of corticotropin-releasing hormone immunoactivity in maternal and fetal plasma during pregnancy. J. Clin. Endocrinol. Metab. 63, 1199\u20131203 (1986).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR22","first-page":"835","volume":"82","author":"P Florio","year":"1997","unstructured":"Florio, P., Woods, R. J., Genazzani, A. R., Lowry, P. J. & Petraglia, F. Changes in amniotic fluid immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein levels in pregnant women at term and during labor. J. Clin. Endocrinol. Metab. 82, 835\u2013838 (1997).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/0003-4819-129-3-199808010-00012","volume":"129","author":"GP Chrousos","year":"1998","unstructured":"Chrousos, G. P., Torpy, D. J. & Gold, P. W. Interactions between the hypothalamic\u2013pituitary\u2013adrenal axis and the female reproductive system: clinical implications. Ann. Intern. Med. 129, 229\u2013240 (1998).","journal-title":"Ann. Intern. Med."},{"key":"BFnrendo2012155_CR24","doi-asserted-by":"crossref","first-page":"5244","DOI":"10.1073\/pnas.85.14.5244","volume":"85","author":"BG Robinson","year":"1988","unstructured":"Robinson, B. G., Emanuel, R. L., Frim, D. M. & Majzoub, J. A. Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc. Natl Acad. Sci. USA 85, 5244\u20135248 (1988).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrendo2012155_CR25","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1210\/jcem-68-4-825","volume":"68","author":"SA Jones","year":"1989","unstructured":"Jones, S. A., Brooks, A. N. & Challis, J. R. Steroids modulate corticotropin-releasing hormone production in human fetal membranes and placenta. J. Clin. Endocrinol. Metab. 68, 825\u2013830 (1989).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR26","first-page":"311","volume":"12","author":"J Bocian-Sobkowska","year":"1997","unstructured":"Bocian-Sobkowska, J., Malendowicz, L. K. & Wozniak, W. Comparative stereological study on zonation and cellular composition of adrenal glands of normal and anencephalic human fetuses. I. Zonation of the gland. Histol. Histopathol. 12, 311\u2013317 (1997).","journal-title":"Histol. Histopathol."},{"key":"BFnrendo2012155_CR27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/509","volume":"19","author":"H Krude","year":"1998","unstructured":"Krude, H. et al. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat. Genet. 19, 155\u2013157 (1998).","journal-title":"Nat. Genet."},{"key":"BFnrendo2012155_CR28","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1172\/JCI200318784","volume":"112","author":"RS Jackson","year":"2003","unstructured":"Jackson, R. S. et al. Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J. Clin. Invest. 112, 1550\u20131560 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo2012155_CR29","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0140-6736(93)90208-X","volume":"341","author":"AJ Clark","year":"1993","unstructured":"Clark, A. J., McLoughlin, L. & Grossman, A. Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor. Lancet 341, 461\u2013462 (1993).","journal-title":"Lancet"},{"key":"BFnrendo2012155_CR30","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng1501","volume":"37","author":"LA Metherell","year":"2005","unstructured":"Metherell, L. A. et al. Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2. Nat. Genet. 37, 166\u2013170 (2005).","journal-title":"Nat. Genet."},{"key":"BFnrendo2012155_CR31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.beem.2006.09.002","volume":"20","author":"LA Metherell","year":"2006","unstructured":"Metherell, L. A., Chan, L. F. & Clark, A. J. The genetics of ACTH resistance syndromes. Best Pract. Res. Clin. Endocrinol. Metab. 20, 547\u2013560 (2006).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR32","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1210\/jc.2009-0467","volume":"94","author":"LA Metherell","year":"2009","unstructured":"Metherell, L. A. et al. Nonclassic lipoid congenital adrenal hyperplasia masquerading as familial glucocorticoid deficiency. J. Clin. Endocrinol. Metab. 94, 3865\u20133871 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR33","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1172\/JCI60224","volume":"122","author":"CR Hughes","year":"2012","unstructured":"Hughes, C. R. et al. MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans. J. Clin. Invest. 122, 814\u2013820 (2012).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo2012155_CR34","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ng.2299","volume":"44","author":"E Meimaridou","year":"2012","unstructured":"Meimaridou, E. et al. Mutations in NNT encoding nicotinamide nucleotide transhydrogenase cause familial glucocorticoid deficiency. Nat. Genet. 44, 740\u2013742 (2012).","journal-title":"Nat. Genet."},{"key":"BFnrendo2012155_CR35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1210\/rp.57.1.19","volume":"57","author":"KL Parker","year":"2002","unstructured":"Parker, K. L. et al. Steroidogenic factor 1: an essential mediator of endocrine development. Recent Prog. Horm. Res. 57, 19\u201336 (2002).","journal-title":"Recent Prog. Horm. Res."},{"key":"BFnrendo2012155_CR36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1210\/mend.15.1.0585","volume":"15","author":"NA Hanley","year":"2001","unstructured":"Hanley, N. A., Rainey, W. E., Wilson, D. I., Ball, S. G. & Parker, K. L. Expression profiles of SF-1, DAX1, and CYP17 in the human fetal adrenal gland: potential interactions in gene regulation. Mol. Endocrinol. 15, 57\u201368 (2001).","journal-title":"Mol. Endocrinol."},{"key":"BFnrendo2012155_CR37","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1210\/jcem.83.8.5027","volume":"83","author":"M Peter","year":"1998","unstructured":"Peter, M., Viemann, M., Partsch, C. J. & Sippell, W. G. Congenital adrenal hypoplasia: clinical spectrum, experience with hormonal diagnosis, and report on new point mutations of the DAX-1 gene. J. Clin. Endocrinol. Metab. 83, 2666\u20132674 (1998).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR38","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0092-8674(94)90050-7","volume":"77","author":"WH Shen","year":"1994","unstructured":"Shen, W. H., Moore, C. C., Ikeda, Y., Parker, K. L. & Ingraham, H. A. Nuclear receptor steroidogenic factor 1 regulates the M\u00fcllerian inhibiting substance gene: a link to the sex determination cascade. Cell 77, 651\u2013661 (1994).","journal-title":"Cell"},{"key":"BFnrendo2012155_CR39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/9629","volume":"22","author":"JC Achermann","year":"1999","unstructured":"Achermann, J. C., Ito, M., Ito, M., Hindmarsh, P. C. & Jameson, J. L. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat. Genet. 22, 125\u2013126 (1999).","journal-title":"Nat. Genet."},{"key":"BFnrendo2012155_CR40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000321213","volume":"20","author":"R El-Khairi","year":"2011","unstructured":"El-Khairi, R., Martinez-Aguayo, A., Ferraz-de-Souza, B., Lin, L. & Achermann, J. C. Role of DAX-1 (NR0B1) and steroidogenic factor-1 (NR5A1) in human adrenal function. Endocr. Dev. 20, 38\u201346 (2011).","journal-title":"Endocr. Dev."},{"key":"BFnrendo2012155_CR41","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1210\/me.2009-0519","volume":"24","author":"BP Schimmer","year":"2010","unstructured":"Schimmer, B. P. & White, P. C. Minireview: steroidogenic factor 1: its roles in differentiation, development, and disease. Mol. Endocrinol. 24, 1322\u20131337 (2010).","journal-title":"Mol. Endocrinol."},{"key":"BFnrendo2012155_CR42","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1210\/jc.2009-2631","volume":"95","author":"PW Speiser","year":"2010","unstructured":"Speiser, P. W. et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 95, 4133\u20134160 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR43","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00431-011-1620-5","volume":"171","author":"O Lekarev","year":"2012","unstructured":"Lekarev, O., Mallet, D., Yuen, T., Morel, Y. & New, M. I. Congenital lipoid adrenal hyperplasia (a rare form of adrenal insufficiency and ambiguous genitalia) caused by a novel mutation of the steroidogenic acute regulatory protein gene. Eur. J. Pediatr. 171, 787\u2013793 (2012).","journal-title":"Eur. J. Pediatr."},{"key":"BFnrendo2012155_CR44","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000321215","volume":"20","author":"B Hauffa","year":"2011","unstructured":"Hauffa, B. & Hiort, O. P450 side-chain cleavage deficiency--a rare cause of congenital adrenal hyperplasia. Endocr. Dev. 20, 54\u201362 (2011).","journal-title":"Endocr. Dev."},{"key":"BFnrendo2012155_CR45","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.beem.2008.10.014","volume":"23","author":"N Krone","year":"2009","unstructured":"Krone, N. & Arlt, W. Genetics of congenital adrenal hyperplasia. Best Pract. Res. Clin. Endocrinol. Metab. 23, 181\u2013192 (2009).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR46","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/ncpendmet0481","volume":"3","author":"S Nimkarn","year":"2007","unstructured":"Nimkarn, S. & New, M. I. Prenatal diagnosis and treatment of congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Nat. Clin. Pract. Endocrinol. Metab. 3, 405\u2013413 (2007).","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR47","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1210\/jcem.86.12.8072","volume":"86","author":"MI New","year":"2001","unstructured":"New, M. I. et al. Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J. Clin. Endocrinol. Metab. 86, 5651\u20135657 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR48","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000321228","volume":"20","author":"S Lajic","year":"2011","unstructured":"Lajic, S., Nordenstr\u00f6m, A. & Hirvikoski, T. Long-term outcome of prenatal dexamethasone treatment of 21-hydroxylase deficiency. Endocr. Dev. 20, 96\u2013105 (2011).","journal-title":"Endocr. Dev."},{"key":"BFnrendo2012155_CR49","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2265.2010.03826.x","volume":"73","author":"M Merc\u00e8 Fern\u00e1ndez-Balsells","year":"2010","unstructured":"Merc\u00e8 Fern\u00e1ndez-Balsells, M. et al. Prenatal dexamethasone use for the prevention of virilization in pregnancies at risk for classical congenital adrenal hyperplasia because of 21-hydroxylase (CYP21A2) deficiency: a systematic review and meta-analyses. Clin. Endocrinol. (Oxf.) 73, 436\u2013444 (2010).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2012155_CR50","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1210\/jc.2008-1414","volume":"94","author":"N Reisch","year":"2009","unstructured":"Reisch, N. et al. High prevalence of reduced fecundity in men with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 94, 1665\u20131670 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR51","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/humrep\/den118","volume":"23","author":"K Hagenfeldt","year":"2008","unstructured":"Hagenfeldt, K. et al. Fertility and pregnancy in outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum. Reprod. 23, 1607\u20131613 (2008).","journal-title":"Hum. Reprod."},{"key":"BFnrendo2012155_CR52","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1365-2265.2009.03563.x","volume":"70","author":"A Caster\u00e0s","year":"2009","unstructured":"Caster\u00e0s, A., De Silva, P., Rumsby, G. & Conway, G. S. Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): normal pregnancy rate but reduced fertility rate. Clin. Endocrinol. (Oxf.) 70, 833\u2013837 (2009).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2012155_CR53","first-page":"930","volume":"84","author":"JC Lo","year":"1999","unstructured":"Lo, J. C. et al. Normal female infants born of mothers with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 84, 930\u2013936 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR54","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1210\/jc.2009-1383","volume":"95","author":"M Bidet","year":"2010","unstructured":"Bidet, M. et al. Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 95, 1182\u20131190 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR55","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ng1300","volume":"36","author":"CE Fl\u00fcck","year":"2004","unstructured":"Fl\u00fcck, C. E. et al. Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley\u2013Bixler syndrome. Nat. Genet. 36, 228\u2013230 (2004).","journal-title":"Nat. Genet."},{"key":"BFnrendo2012155_CR56","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/pd.2588","volume":"30","author":"WY Craig","year":"2010","unstructured":"Craig, W. Y. et al. Prevalence of steroid sulfatase deficiency in California according to race and ethnicity. Prenat. Diagn. 30, 893\u2013898 (2010).","journal-title":"Prenat. Diagn."},{"key":"BFnrendo2012155_CR57","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/BF01800173","volume":"5","author":"NF Taylor","year":"1982","unstructured":"Taylor, N. F. Review: placental sulphatase deficiency. J. Inherit. Metab. Dis. 5, 164\u2013176 (1982).","journal-title":"J. Inherit. Metab. Dis."},{"key":"BFnrendo2012155_CR58","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2265.2011.04012.x","volume":"75","author":"A Hauri-Hohl","year":"2011","unstructured":"Hauri-Hohl, A. et al. Aromatase deficiency due to a functional variant in the placenta promoter and a novel missense mutation in the CYP19A1 gene. Clin. Endocrinol. (Oxf.) 75, 39\u201343 (2011).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2012155_CR59","first-page":"3689","volume":"80","author":"A Morishima","year":"1995","unstructured":"Morishima, A., Grumbach, M. M., Simpson, E. R., Fisher, C. & Qin, K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J. Clin. Endocrinol. Metab. 80, 3689\u20133698 (1995).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR60","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1210\/jcem-68-5-863","volume":"68","author":"HG D\u00f6rr","year":"1989","unstructured":"D\u00f6rr, H. G. et al. Longitudinal study of progestins, mineralocorticoids, and glucocorticoids throughout human pregnancy. J. Clin. Endocrinol. Metab. 68, 863\u2013868 (1989).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR61","first-page":"249","volume":"17","author":"RL Landau","year":"1961","unstructured":"Landau, R. L. & Lugibihl, K. The catabolic and natriuretic effects of progesterone in man. Recent Prog. Horm. Res. 17, 249\u2013292 (1961).","journal-title":"Recent Prog. Horm. Res."},{"key":"BFnrendo2012155_CR62","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0002-9378(83)90312-5","volume":"145","author":"CR Parker Jr.","year":"1983","unstructured":"Parker, C. R., Jr., Cutrer, S., Casey, M. L. & MacDonald, P. C. Concentrations of deoxycorticosterone, deoxycorticosterone sulfate, and progesterone in maternal venous serum and umbilical arterial and venous sera. Am. J. Obstet. Gynecol. 145, 427\u2013432 (1983).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"BFnrendo2012155_CR63","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1210\/edrv-3-4-396","volume":"3","author":"ML Casey","year":"1982","unstructured":"Casey, M. L. & MacDonald, P. C. Extraadrenal formation of a mineralocorticosteroid: deoxycorticosterone and deoxycorticosterone sulfate biosynthesis and metabolism. Endocr. Rev. 3, 396\u2013403 (1982).","journal-title":"Endocr. Rev."},{"key":"BFnrendo2012155_CR64","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/0002-9378(81)90318-5","volume":"139","author":"BR Carr","year":"1981","unstructured":"Carr, B. R., Parker, C. R. Jr, Madden, J. D., MacDonald, P. C. & Porter, J. C. Maternal plasma adrenocorticotropin and cortisol relationships throughout human pregnancy. Am. J. Obstet. Gynecol. 139, 416\u2013422 (1981).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"BFnrendo2012155_CR65","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/bmj.2.5660.798","volume":"2","author":"CW Burke","year":"1969","unstructured":"Burke, C. W. Biologically active cortisol in plasma of oestrogen-treated and normal subjects. Br. Med. J. 2, 798\u2013800 (1969).","journal-title":"Br. Med. J."},{"key":"BFnrendo2012155_CR66","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1210\/jcem-65-1-176","volume":"65","author":"A Sasaki","year":"1987","unstructured":"Sasaki, A. et al. Immunoreactive corticotropin-releasing hormone present in human plasma may be derived from both hypothalamic and extrahypothalamic sources. J. Clin. Endocrinol. Metab. 65, 176\u2013182 (1987).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR67","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1210\/jcem-23-12-1298","volume":"23","author":"EE Baulieu","year":"1963","unstructured":"Baulieu, E. E. & Dray, F. Conversion of H3-dehydroisoandrosterone (3\u03b2-hydroxy-\u03945-androsten-17-one) sulfate to H3-estrogens in normal pregnant women. J. Clin. Endocrinol. Metab. 23, 1298\u20131301 (1963).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR68","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1210\/jcem-50-1-117","volume":"50","author":"S B\u00e9lisle","year":"1980","unstructured":"B\u00e9lisle, S., Schiff, I. & Tulchinsky, D. The use of constant infusion of unlabeled dehydroepiandrosterone for the assessment of its metabolic clearance rate, its half-life, and its conversion into estrogens. J. Clin. Endocrinol. Metab. 50, 117\u2013121 (1980).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR69","first-page":"200","volume":"23","author":"MG Crane","year":"1964","unstructured":"Crane, M. G., Andes, J. P., Harris, J. J. & Slate, W. G. Primary aldosteronism in pregnancy. Obstet. Gynecol. 23, 200\u2013208 (1964).","journal-title":"Obstet. Gynecol."},{"key":"BFnrendo2012155_CR70","doi-asserted-by":"crossref","first-page":"273.e1","DOI":"10.1016\/j.ajog.2007.05.047","volume":"197","author":"CV Ananth","year":"2007","unstructured":"Ananth, C. V., Peltier, M. R., Kinzler, W. L., Smulian, J. C. & Vintzileos, A. M. Chronic hypertension and risk of placental abruption: is the association modified by ischemic placental disease? Am. J. Obstet. Gynecol. 197, 273.e1\u2013273.e7 (2007).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"BFnrendo2012155_CR71","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00006250-200208000-00029","volume":"100","author":"BM Sibai","year":"2002","unstructured":"Sibai, B. M. Chronic hypertension in pregnancy. Obstet. Gynecol. 100, 369\u2013377 (2002).","journal-title":"Obstet. Gynecol."},{"key":"BFnrendo2012155_CR72","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1161\/HYPERTENSIONAHA.107.107565","volume":"51","author":"LC Chappell","year":"2008","unstructured":"Chappell, L. C. et al. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study. Hypertension 51, 1002\u20131009 (2008).","journal-title":"Hypertension"},{"key":"BFnrendo2012155_CR73","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1365-2265.2010.03901.x","volume":"74","author":"V Ronconi","year":"2011","unstructured":"Ronconi, V., Turchi, F., Zennaro, M. C., Boscaro, M. & Giacchetti, G. Progesterone increase counteracts aldosterone action in a pregnant woman with primary aldosteronism. Clin. Endocrinol. (Oxf.) 74, 278\u2013279 (2011).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2012155_CR74","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1210\/jcem-27-11-1628","volume":"27","author":"EG Biglieri","year":"1967","unstructured":"Biglieri, E. G. & Slaton, P. E. Jr. Pregnancy and primary aldosteronism. J. Clin. Endocrinol. Metab. 27, 1628\u20131632 (1967).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR75","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1536\/ihj.19.946","volume":"19","author":"W Aoi","year":"1978","unstructured":"Aoi, W. et al. Primary aldosteronism aggravated during peripartum period. Jpn Heart J. 19, 946\u2013953 (1978).","journal-title":"Jpn Heart J."},{"key":"BFnrendo2012155_CR76","first-page":"1685","volume":"4","author":"RD Gordon","year":"1982","unstructured":"Gordon, R. D. & Tunny, T. J. Aldosterone-producing-adenoma (A-P-A): effect of pregnancy. Clin. Exp. Hypertens. A 4, 1685\u20131693 (1982).","journal-title":"Clin. Exp. Hypertens. A"},{"key":"BFnrendo2012155_CR77","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/S0140-6736(00)03311-0","volume":"356","author":"T Murakami","year":"2000","unstructured":"Murakami, T., Watanabe Ogura, E., Tanaka, Y. & Yamamoto, M. High blood pressure lowered by pregnancy. Lancet 356, 1980 (2000).","journal-title":"Lancet"},{"key":"BFnrendo2012155_CR78","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1210\/jc.2003-030092","volume":"88","author":"M Quinkler","year":"2003","unstructured":"Quinkler, M., Meyer, B., Oelkers, W. & Diederich, S. Renal inactivation, mineralocorticoid generation, and 11beta-hydroxysteroid dehydrogenase inhibition ameliorate the antimineralocorticoid effect of progesterone in vivo. J. Clin. Endocrinol. Metab. 88, 3767\u20133772 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR79","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/EJE-10-0879","volume":"164","author":"NM Albiger","year":"2011","unstructured":"Albiger, N. M. et al. A case of primary aldosteronism in pregnancy: do LH and GNRH receptors have a potential role in regulating aldosterone secretion? Eur. J. Endocrinol. 164, 405\u2013412 (2011).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo2012155_CR80","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1161\/01.HYP.35.2.668","volume":"35","author":"JA Wyckoff","year":"2000","unstructured":"Wyckoff, J. A. et al. Glucocorticoid-remediable aldosteronism and pregnancy. Hypertension 35, 668\u2013672 (2000).","journal-title":"Hypertension"},{"key":"BFnrendo2012155_CR81","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","volume":"93","author":"J Funder","year":"2008","unstructured":"Funder, J. et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 93, 3266\u20133281 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR82","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/BF03349319","volume":"2","author":"M Messina","year":"1979","unstructured":"Messina, M., Biffignandi, P., Ghigo, E., Jeantet, M. G. & Molinatti, G. M. Possible contraindication of spironolactone during pregnancy. J. Endocrinol. Invest. 2, 222 (1979).","journal-title":"J. Endocrinol. Invest."},{"key":"BFnrendo2012155_CR83","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/0002-9378(95)90549-9","volume":"172","author":"TD Groves","year":"1995","unstructured":"Groves, T. D. & Corenblum, B. Spironolactone therapy during human pregnancy. Am. J. Obstet. Gynecol. 172, 1655\u20131656 (1995).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"BFnrendo2012155_CR84","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/eurheartj\/ehr272","volume":"32","author":"V Regitz-Zagrosek","year":"2011","unstructured":"Regitz-Zagrosek, V. et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur. Heart J. 32, 3147\u20133197 (2011).","journal-title":"Eur. Heart J."},{"key":"BFnrendo2012155_CR85","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1080\/01443610701667098","volume":"27","author":"NA Al-Ali","year":"2007","unstructured":"Al-Ali, N. A., El-Sandabesee, D., Steel, S. A. & Roland, J. M. Conn's syndrome in pregnancy successfully treated with amiloride. J. Obstet. Gynaecol 27, 730\u2013731 (2007).","journal-title":"J. Obstet. Gynaecol"},{"key":"BFnrendo2012155_CR86","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/HYPERTENSIONAHA.111.187237","volume":"59","author":"A Cabassi","year":"2012","unstructured":"Cabassi, A., Rocco, R., Berretta, R., Regolisti, G. & Bacchi-Modena, A. Eplerenone use in primary aldosteronism during pregnancy. Hypertension 59, e18\u2013e19 (2012).","journal-title":"Hypertension"},{"key":"BFnrendo2012155_CR87","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman, L. K. et al. The diagnosis of Cushing's syndrome: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 93, 1526\u20131540 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR88","first-page":"3083","volume":"83","author":"J Lado-Abeal","year":"1998","unstructured":"Lado-Abeal, J. et al. Menstrual abnormalities in women with Cushing's disease are correlated with hypercortisolemia rather than raised circulating androgen levels. J. Clin. Endocrinol. Metab. 83, 3083\u20133088 (1998).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR89","first-page":"130","volume":"79","author":"MA Buescher","year":"1992","unstructured":"Buescher, M. A., McClamrock, H. D. & Adashi, E. Y. Cushing syndrome in pregnancy. Obstet. Gynecol. 79, 130\u2013137 (1992).","journal-title":"Obstet. Gynecol."},{"key":"BFnrendo2012155_CR90","first-page":"15","volume":"81","author":"C Wallace","year":"1996","unstructured":"Wallace, C., Toth, E. L., Lewanczuk, R. Z. & Siminoski, K. Pregnancy-induced Cushing's syndrome in multiple pregnancies. J. Clin. Endocrinol. Metab. 81, 15\u201321 (1996).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR91","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2265.1993.tb02380.x","volume":"39","author":"CF Close","year":"1993","unstructured":"Close, C. F., Mann, M. C., Watts, J. F. & Taylor, K. G. ACTH-independent Cushing's syndrome in pregnancy with spontaneous resolution after delivery: control of the hypercortisolism with metyrapone. Clin. Endocrinol. (Oxf.) 39, 375\u2013379 (1993).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2012155_CR92","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s12022-009-9090-2","volume":"20","author":"MH Chui","year":"2009","unstructured":"Chui, M. H. et al. Case report: Adrenal LH\/hCG receptor overexpression and gene amplification causing pregnancy-induced Cushing's syndrome. Endocr. Pathol. 20, 256\u2013261 (2009).","journal-title":"Endocr. Pathol."},{"key":"BFnrendo2012155_CR93","first-page":"75","volume":"22","author":"A Lacroix","year":"2001","unstructured":"Lacroix, A., Ndiaye, N., Tremblay, J. & Hamet, P. Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocr. Rev. 22, 75\u2013110 (2001).","journal-title":"Endocr. Rev."},{"key":"BFnrendo2012155_CR94","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF03345718","volume":"32","author":"E Rask","year":"2009","unstructured":"Rask, E. et al. Adrenocorticotropin-independent Cushing's syndrome in pregnancy related to overexpression of adrenal luteinizing hormone\/human chorionic gonadotropin receptors. J. Endocrinol. Invest. 32, 313\u2013316 (2009).","journal-title":"J. Endocrinol. Invest."},{"key":"BFnrendo2012155_CR95","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/gye.16.5.413.417","volume":"16","author":"LA Wy","year":"2002","unstructured":"Wy, L. A. et al. Pregnancy-associated Cushing's syndrome secondary to a luteinizing hormone\/human chorionic gonadotropin receptor-positive adrenal carcinoma. Gynecol. Endocrinol. 16, 413\u2013417 (2002).","journal-title":"Gynecol. Endocrinol."},{"key":"BFnrendo2012155_CR96","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1210\/jc.2004-2361","volume":"90","author":"JR Lindsay","year":"2005","unstructured":"Lindsay, J. R., Jonklaas, J., Oldfield, E. H. & Nieman, L. K. Cushing's syndrome during pregnancy: personal experience and review of the literature. J. Clin. Endocrinol. Metab. 90, 3077\u20133083 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR97","first-page":"1072","volume":"108","author":"VE Pricolo","year":"1990","unstructured":"Pricolo, V. E. et al. Management of Cushing's syndrome secondary to adrenal adenoma during pregnancy. Surgery 108, 1072\u20131077 (1990).","journal-title":"Surgery"},{"key":"BFnrendo2012155_CR98","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1210\/jc.2010-0445","volume":"95","author":"MM Erichsen","year":"2010","unstructured":"Erichsen, M. M., Husebye, E. S., Michelsen, T. M., Dahl, A. A. & L\u00f8v\u00e5s, K. Sexuality and fertility in women with Addison's disease. J. Clin. Endocrinol. Metab. 95, 4354\u20134360 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR99","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1210\/jc.2010-0108","volume":"95","author":"S Bj\u00f6rnsdottir","year":"2010","unstructured":"Bj\u00f6rnsdottir, S. et al. Addison's disease in women is a risk factor for an adverse pregnancy outcome. J. Clin. Endocrinol. Metab. 95, 5249\u20135257 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR100","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1172\/JCI116843","volume":"92","author":"O Winqvist","year":"1993","unstructured":"Winqvist, O., Gustafsson, J., Rorsman, F., Karlsson, F. A. & K\u00e4mpe, O. Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease. J. Clin. Invest. 92, 2377\u20132385 (1993).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo2012155_CR101","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/00016348909009909","volume":"68","author":"E Albert","year":"1989","unstructured":"Albert, E., Dalaker, K., Jorde, R. & Berge, L. N. Addison's disease and pregnancy. Acta Obstet. Gynecol. Scand. 68, 185\u2013187 (1989).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"BFnrendo2012155_CR102","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/BF03347034","volume":"26","author":"B Ambrosi","year":"2003","unstructured":"Ambrosi, B., Barbetta, L. & Morricone, L. Diagnosis and management of Addison's disease during pregnancy. J. Endocrinol. Invest. 26, 698\u2013702 (2003).","journal-title":"J. Endocrinol. Invest."},{"key":"BFnrendo2012155_CR103","doi-asserted-by":"crossref","first-page":"1199.e17","DOI":"10.1016\/j.fertnstert.2007.08.079","volume":"90","author":"C Fux Otta","year":"2008","unstructured":"Fux Otta, C., Szafryk de Mereshian, P., Iraci, G. S. & Ojeda de Pruneda, M. R. Pregnancies associated with primary adrenal insufficiency. Fertil. Steril. 90, 1199.e17\u20131199.e20 (2008).","journal-title":"Fertil. Steril."},{"key":"BFnrendo2012155_CR104","first-page":"923","volume":"79","author":"SK Grinspoon","year":"1994","unstructured":"Grinspoon, S. K. & Biller, B. M. Clinical review 62: Laboratory assessment of adrenal insufficiency. J. Clin. Endocrinol. Metab. 79, 923\u2013931 (1994).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR105","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1210\/jc.2006-1049","volume":"91","author":"D Suri","year":"2006","unstructured":"Suri, D., Moran, J., Hibbard, J. U., Kasza, K. & Weiss, R. E. Assessment of adrenal reserve in pregnancy: defining the normal response to the adrenocorticotropin stimulation test. J. Clin. Endocrinol. Metab. 91, 3866\u20133872 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2012155_CR106","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0002-9378(84)90206-0","volume":"149","author":"D Drucker","year":"1984","unstructured":"Drucker, D., Shumak, S. & Angel, A. Schmidt's syndrome presenting with intrauterine growth retardation and postpartum addisonian crisis. Am. J. Obstet. Gynecol. 149, 229\u2013230 (1984).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"BFnrendo2012155_CR107","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","volume":"366","author":"JW Lenders","year":"2005","unstructured":"Lenders, J. W., Eisenhofer, G., Mannelli, M. & Pacak, K. Phaeochromocytoma. Lancet 366, 665\u2013675 (2005).","journal-title":"Lancet"},{"key":"BFnrendo2012155_CR108","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1530\/EJE-11-0528","volume":"166","author":"JW Lenders","year":"2012","unstructured":"Lenders, J. W. Pheochromocytoma and pregnancy: a deceptive connection. Eur. J. Endocrinol. 166, 143\u2013150 (2012).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo2012155_CR109","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/00006254-197111000-00001","volume":"26","author":"JG Schenker","year":"1971","unstructured":"Schenker, J. G. & Chowers, I. Pheochromocytoma and pregnancy. Review of 89 cases. Obstet. Gynecol. Surv. 26, 739\u2013747 (1971).","journal-title":"Obstet. Gynecol. Surv."},{"key":"BFnrendo2012155_CR110","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/00006254-199911000-00025","volume":"54","author":"SK Ahlawat","year":"1999","unstructured":"Ahlawat, S. K., Jain, S., Kumari, S., Varma, S. & Sharma, B. K. Pheochromocytoma associated with pregnancy: case report and review of the literature. Obstet. Gynecol. Surv. 54, 728\u2013737 (1999).","journal-title":"Obstet. Gynecol. Surv."},{"key":"BFnrendo2012155_CR111","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMcps0708258","volume":"361","author":"AS Desai","year":"2009","unstructured":"Desai, A. S., Chutkow, W. A., Edelman, E., Economy, K. E. & Dec, G. W. Jr. A crisis in late pregnancy. N. Engl. J. Med. 361, 2271\u20132277 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo2012155_CR112","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijoa.2005.11.003","volume":"15","author":"JG Hudsmith","year":"2006","unstructured":"Hudsmith, J. G., Thomas, C. E. & Browne, D. A. Undiagnosed phaeochromocytoma mimicking severe preeclampsia in a pregnant woman at term. Int. J. Obstet. Anesth. 15, 240\u2013245 (2006).","journal-title":"Int. J. Obstet. Anesth."},{"key":"BFnrendo2012155_CR113","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1001\/archsurg.1988.01400320042007","volume":"123","author":"KA Newell","year":"1988","unstructured":"Newell, K. A. et al. Pheochromocytoma multisystem crisis. A surgical emergency. Arch. Surg. 123, 956\u2013959 (1988).","journal-title":"Arch. Surg."},{"key":"BFnrendo2012155_CR114","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1530\/EJE-11-0162","volume":"165","author":"C Lentschener","year":"2011","unstructured":"Lentschener, C., Gaujoux, S., Tesniere, A. & Dousset, B. Point of controversy: perioperative care of patients undergoing pheochromocytoma removal-time for a reappraisal? Eur. J. Endocrinol. 165, 365\u2013373 (2011).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo2012155_CR115","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/BF03345503","volume":"25","author":"M Mannelli","year":"2002","unstructured":"Mannelli, M. & Bemporad, D. Diagnosis and management of pheochromocytoma during pregnancy. J. Endocrinol. Invest. 25, 567\u2013571 (2002).","journal-title":"J. Endocrinol. Invest."},{"key":"BFnrendo2012155_CR116","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1471-0528.1982.tb04661.x","volume":"89","author":"PG Natrajan","year":"1982","unstructured":"Natrajan, P. G., McGarrigle, H. H., Lawrence, D. M. & Lachelin, G. C. Plasma noradrenaline and adrenaline levels in normal pregnancy and in pregnancy-induced hypertension. Br. J. Obstet. Gynaecol 89, 1041\u20131045 (1982).","journal-title":"Br. J. Obstet. Gynaecol"},{"key":"BFnrendo2012155_CR117","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1210\/jcem-30-3-357","volume":"30","author":"FP Zuspan","year":"1970","unstructured":"Zuspan, F. P. Urinary excretion of epinephrine and norepinephrine during pregnancy. J. Clin. Endocrinol. Metab. 30, 357\u2013360 (1970).","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2012.155","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2012.155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2012.155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T03:34:02Z","timestamp":1714361642000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrendo.2012.155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,11]]},"references-count":117,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["BFnrendo2012155"],"URL":"https:\/\/doi.org\/10.1038\/nrendo.2012.155","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,11]]}}}